Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine

Brain and Development

Volumn 33, Issue 4, 2011, Pages 332-334

  Omata, Taku ^a   Takanashi, Jun ichi ^b   Wada, Takahito ^c   Arai, Hidee ^a   Tanabe, Yuzo ^a  

^a CHIBA CHILDREN'S HOSPITAL   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

^c KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

Acetazolamide; CACNA1A; Cerebellar atrophy; Familial hemiplegic migraine; T666M

Indexed keywords

ACETAZOLAMIDE; PARACETAMOL;

ADULT; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CLINICAL FEATURE; DRUG EFFICACY; FAMILIAL HEMIPLEGIC MIGRAINE; FEMALE; GENE MUTATION; HEADACHE; HEMIPLEGIA; HUMAN; MIGRAINE AURA; NEUROIMAGING; NYSTAGMUS; SYMPTOM;

ACETAZOLAMIDE; ADOLESCENT; ANTICONVULSANTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIGRAINE WITH AURA; MUTATION; TREATMENT OUTCOME;

EID: 79952313893     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.05.006     Document Type: Article

References (9)

1. Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J., Hoffman S.M., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
2. De Fusco M., Marconi R., Silvestri L., Atorino L., Rampoldi L., Morgante L., et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 2003, 33:192-196.
3. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366(9483):371-377.
4. Ducros A., Denier C., Joutel A., Cecillon M., Lescoat C., Vahedi K., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 2001, 345:17-24.
5. Barkovich A.J. Toxic and metabolic brain disorders. Pediatric Neuroimaging. fourth ed. 2005, 76-189. Lippincott, Williams & Wilkins, Philadelphia. A.J. Barkovich (Ed.).
6. Wada T., Kobayashi N., Takahashi Y., Aoki T., Watanabe T., Saitoh S. Wide clinical variability in a family with a CACNA1A T666M mutation: hemiplegic migraine, coma, and progressive ataxia. Pediatr. Neurol. 2002, 26:47-50.
7. Athwal B.S., Lennox G.G. Acetazolamide responsiveness in familial hemiplegic migraine. Ann. Neurol. 1996, 40:820-821.
8. Battistini S., Stenirri S., Piatti M., Gelfi C., Righetti P.G., Rocchi R., et al. A new CACNA1A gene mutation in acetazolamide-responsible familial hemiplegic migraine and ataxia. Neurology 1999, 13(53):38-43.
9. Haan J., Sluis P., Sluis L.H., Ferrari M.D. Acetazolamide treatment for migraine aura status. Neurology 2000, 55:1558-1559.